Clinical Trials

Vial announces Collaborative Alliance with Mason

Vial, a global tech-driven contract research organization (CRO) providing next-generation clinical trial management services, has announced its strategic partnership with Mason America Inc. (“Mason”), a provider of mobile infrastructure for smart hardware products. As part of the collaboration, Mason will provide Vial with hardware as a service for clinical sites, enabling remote management of devices for eSource at a global scale. This partnership empowers Vial to focus on accelerating the development of new therapies and devices for its sponsors and patients.

Vial, led by CEO and Co-Founder Simon Burns, promises to deliver faster, more efficient trials for biotech sponsors while maintaining cost-effectiveness. The Vial CRO distinguishes itself by leveraging digital technology, such as its technology platform, combining eSource, EDC, and ePRO in one connected system to streamline site processes. Vial EDC is a modern, intuitive, and hyper-responsive EDC platform powered by eSource. Vial’s technology delivers a consumer-grade experience and next-generation performance to eClinical software.

“Vial’s mission is to bring innovation and efficiency to clinical trials. Our partnership with Mason allows us to leverage cutting-edge technology and hardware infrastructure to bring direct data capture into reality, and ensure seamless shipping, setup, and user experiences at clinical sites,” stated Simon Burns, CEO and Co-Founder of Vial.

Mason, founded by President Jim Xiao, is enthusiastic about joining forces with Vial in this venture. “We are excited to collaborate with Vial to transform the clinical trial landscape globally. Mason’s infrastructure and hardware expertise, coupled with Vial’s commitment to innovation, will undoubtedly bring about groundbreaking changes in the healthcare and biotech sectors,” said Jim Xiao, President of Mason.

The collaboration between Vial and Mason has already yielded significant results, with Mason’s tablets successfully deployed to clinical trial sites across the United States. These tablets are now actively in use on Vial-conducted trials, streamlining data collection and providing a seamless eSource experience for healthcare professionals and patients alike.

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

Syneos Health and uMotif to Deliver Patient-centric eClinical Platform

Globe Newswire

Elligo Health Research expands Study Marketplace with Syneos Health

Business Wire

Emmes acquires VaxTRIALS

PR Newswire